Establishment Labs Completes Enrollment in Motiva US IDE Study
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Establishment Labs Holdings Inc., which develops breast aesthetics and reconstruction devices, has completed enrollment in the Motiva US IDE clinical study for breast implants.
Patients living in areas with limited access to healthy foods had higher rates of postoperative complications.